Education
About Us
Working with TipRanks
Follow Us
Bajaj Healthcare Ltd (IN:BAJAJHCARE)
:BAJAJHCARE
BAJAJHCARE Stock Chart & Stats
₹418.50
-₹31.80(-5.51%)
At close: 4:00 PM EST
₹418.50
-₹31.80(-5.51%)
Day’s Range― - ―
52-Week Range₹329.90 - ₹744.90
Previous CloseN/A
Volume215.90K
Average Volume (3M)4.99K
Market Cap
₹11.32B
Enterprise Value₹13.24B
Total Cash (Recent Filing)₹44.51M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)22.7
Beta0.99
Next Earnings
Jun 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.24%
Share Statistics
EPS (TTM)4.96
Shares Outstanding31,583,252
10 Day Avg. Volume2,706
30 Day Avg. Volume4,987
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)4.64
Price to Sales (P/S)3.98
P/FCF Ratio-124.79
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified API And Formulations BusinessOperating both API/intermediate manufacturing and finished formulations provides multiple durable revenue streams and B2B contract-manufacturing relationships. Vertical breadth supports resilience to demand shifts, cross-selling opportunities, export/domestic exposure, and steadier long-term cash generation.
Solid Recent Revenue GrowthReported ~17% revenue growth demonstrates continued commercial traction across products and markets. Sustained mid-teens top-line growth over months supports better capacity utilization and pricing leverage, forming a foundation for margin recovery and improved cash conversion if cost controls hold.
Improved Equity RatioAn improving equity ratio signals incremental balance-sheet repair, lowering insolvency risk and enhancing the company's ability to fund working capital internally. Over the medium term this increases financial flexibility and can improve borrowing terms versus prior leverage levels.
Bears Say
High LeverageA relatively high debt-to-equity ratio raises fixed interest and principal obligations, constraining strategic investment and operational flexibility. Over 2–6 months, elevated leverage increases refinancing and solvency risk, particularly if cash flows remain uneven or cost pressures persist.
Inconsistent Cash Flow And Negative FCFIrregular operating cash flow and recent negative free cash flow indicate difficulty turning profits into liquidity. This forces reliance on external financing for working capital and capex, raising liquidity risk and limiting the company's ability to deleverage or invest in growth initiatives.
Margin Compression And Revenue VolatilityDecreasing gross and EBIT margins alongside uneven revenue point to cost pressures and unstable demand or product mix. Persistent margin compression reduces internal cash generation and makes long-term profitability highly sensitive to raw material costs and competitive pricing dynamics.
Bajaj Healthcare Ltd News
BAJAJHCARE FAQ
What was Bajaj Healthcare Ltd’s price range in the past 12 months?
Bajaj Healthcare Ltd lowest stock price was ₹329.90 and its highest was ₹744.90 in the past 12 months.
What is Bajaj Healthcare Ltd’s market cap?
Bajaj Healthcare Ltd’s market cap is ₹11.32B.
When is Bajaj Healthcare Ltd’s upcoming earnings report date?
Bajaj Healthcare Ltd’s upcoming earnings report date is Jun 02, 2026 which is in 97 days.
How were Bajaj Healthcare Ltd’s earnings last quarter?
Bajaj Healthcare Ltd released its earnings results on Jan 16, 2026. The company reported ₹4.963 earnings per share for the quarter, beating the consensus estimate of N/A by ₹4.963.
Is Bajaj Healthcare Ltd overvalued?
According to Wall Street analysts Bajaj Healthcare Ltd’s price is currently Overvalued.
Does Bajaj Healthcare Ltd pay dividends?
Bajaj Healthcare Ltd pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.24%. See more information on Bajaj Healthcare Ltd dividends here
What is Bajaj Healthcare Ltd’s EPS estimate?
Bajaj Healthcare Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bajaj Healthcare Ltd have?
Bajaj Healthcare Ltd has 31,583,252 shares outstanding.
What happened to Bajaj Healthcare Ltd’s price movement after its last earnings report?
Bajaj Healthcare Ltd reported an EPS of ₹4.963 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.8%.
Which hedge fund is a major shareholder of Bajaj Healthcare Ltd?
Currently, no hedge funds are holding shares in IN:BAJAJHCARE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bajaj Healthcare Ltd
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, and supplies amino acids, nutritional supplements, and active pharmaceutical ingredients (APIs) for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company's product portfolio consists of various APIs in the therapeutic categories of anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, antihelmintic, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, venous disease, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, anticonvulsant, lipotropic agents, nootropic, vasoprotective/ antihemorrhagic, cardiovascular agent, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It also provides formulations in the form of tablets, capsules, and powder, as well as impurities. In addition, the company exports its products. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.
Technical Analysis
Bliss Gvs Pharma Limited
―
Hester Biosciences Limited
―
Jagsonpal Pharmaceuticals Ltd.
―
Syncom Formulation (India) Ltd.
―
Themis Medicare Limited
―